Hong Chang Tan1, Chin Meng Khoo2,3, Matthew Zhen-Wei Tan4, Jean-Paul Kovalik3, Alvin Choong Meng Ng5, Alvin Kim Hock Eng6, Oi Fah Lai7, Jian Hong Ching3, Kwang Wei Tham4, Shanker Pasupathy8. 1. Department of Endocrinology, Singapore General Hospital, The Academia Level 3, 20 College Road, Singapore, 169856, Singapore. tan.hong.chang@sgh.com.sg. 2. Department of Medicine, National University of Singapore, Singapore, Singapore. 3. Cardiovascular Metabolic Program, DUKE-NUS Graduate Medical School, Singapore, Singapore. 4. Department of Endocrinology, Singapore General Hospital, The Academia Level 3, 20 College Road, Singapore, 169856, Singapore. 5. The Endocrine Clinic, Mount Elizabeth Novena Specialist Centre, Singapore, Singapore. 6. Department of Upper GI and Bariatric Surgery, Singapore General Hospital, Singapore, Singapore. 7. Department of Clinical Research, Singapore General Hospital, Singapore, Singapore. 8. Advanced Laparoscopic Surgery, Gleneagles Hospital, Singapore, Singapore.
Abstract
BACKGROUND: Weight loss, early after Roux-en-Y gastric bypass (GB) surgery, is associated with reduced concentrations of plasma branched-chain amino acids (BCAAs) and improved insulin sensitivity. Herein, we evaluated whether changes in BCAAs and insulin sensitivity persist with weight stabilization (1 year) after GB or sleeve gastrectomy (SG). METHODS: We prospectively examined 22 severely obese patients (mean age 40.6 ± 2.1 years, BMI 38.8 ± 1.3 kg/m(2), and 59.1 % female) who underwent SG (n = 12) or GB (n = 10) for morbid obesity. Body fat composition was measured with dual X-Ray absorptiometry and abdominal fat volume with computed tomography. BCAAs and acylcarnitines were profiled using liquid chromatography with tandem mass spectrometry. Insulin resistance was calculated using the homeostasis model assessment for insulin resistance (HOMA-IR) formula. RESULTS: At 1-year follow-up, the decrease in BMI, body weight, total fat mass (TFM), fat free mass, and visceral adipose tissue (VAT) was similar between SG and GB. HOMA-IR was associated with BCAA concentrations, and both were decreased equally in both surgical groups. In multivariate analysis with BCAAs, TFM, and VAT as independent factors, only VAT remained significantly associated with insulin resistance. CONCLUSIONS: The metabolic benefits from bariatric surgery, including the changes in BCAA profile, are comparable between SG and GB. The reduction in BCAAs and improvement in the AC profiles after bariatric surgery persists up to 12 months after surgery and may not be surgical related but is influenced primarily by the amount of weight loss, in particular the reduction in visceral adiposity.
BACKGROUND:Weight loss, early after Roux-en-Y gastric bypass (GB) surgery, is associated with reduced concentrations of plasma branched-chain amino acids (BCAAs) and improved insulin sensitivity. Herein, we evaluated whether changes in BCAAs and insulin sensitivity persist with weight stabilization (1 year) after GB or sleeve gastrectomy (SG). METHODS: We prospectively examined 22 severely obesepatients (mean age 40.6 ± 2.1 years, BMI 38.8 ± 1.3 kg/m(2), and 59.1 % female) who underwent SG (n = 12) or GB (n = 10) for morbid obesity. Body fat composition was measured with dual X-Ray absorptiometry and abdominal fat volume with computed tomography. BCAAs and acylcarnitines were profiled using liquid chromatography with tandem mass spectrometry. Insulin resistance was calculated using the homeostasis model assessment for insulin resistance (HOMA-IR) formula. RESULTS: At 1-year follow-up, the decrease in BMI, body weight, total fat mass (TFM), fat free mass, and visceral adipose tissue (VAT) was similar between SG and GB. HOMA-IR was associated with BCAA concentrations, and both were decreased equally in both surgical groups. In multivariate analysis with BCAAs, TFM, and VAT as independent factors, only VAT remained significantly associated with insulin resistance. CONCLUSIONS: The metabolic benefits from bariatric surgery, including the changes in BCAA profile, are comparable between SG and GB. The reduction in BCAAs and improvement in the AC profiles after bariatric surgery persists up to 12 months after surgery and may not be surgical related but is influenced primarily by the amount of weight loss, in particular the reduction in visceral adiposity.
Authors: Jeffrey I Mechanick; Robert F Kushner; Harvey J Sugerman; J Michael Gonzalez-Campoy; Maria L Collazo-Clavell; Safak Guven; Adam F Spitz; Caroline M Apovian; Edward H Livingston; Robert Brolin; David B Sarwer; Wendy A Anderson; John Dixon Journal: Surg Obes Relat Dis Date: 2008-08-19 Impact factor: 4.734
Authors: Blandine Laferrère; David Reilly; Sara Arias; Nicholas Swerdlow; Prakash Gorroochurn; Baani Bawa; Mousumi Bose; Julio Teixeira; Robert D Stevens; Brett R Wenner; James R Bain; Michael J Muehlbauer; Andrea Haqq; Lillian Lien; Svati H Shah; Laura P Svetkey; Christopher B Newgard Journal: Sci Transl Med Date: 2011-04-27 Impact factor: 17.956
Authors: Christopher B Newgard; Jie An; James R Bain; Michael J Muehlbauer; Robert D Stevens; Lillian F Lien; Andrea M Haqq; Svati H Shah; Michelle Arlotto; Cris A Slentz; James Rochon; Dianne Gallup; Olga Ilkayeva; Brett R Wenner; William S Yancy; Howard Eisenson; Gerald Musante; Richard S Surwit; David S Millington; Mark D Butler; Laura P Svetkey Journal: Cell Metab Date: 2009-04 Impact factor: 27.287
Authors: Pengxiang She; Cynthia Van Horn; Tanya Reid; Susan M Hutson; Robert N Cooney; Christopher J Lynch Journal: Am J Physiol Endocrinol Metab Date: 2007-10-09 Impact factor: 4.310
Authors: Deborah M Muoio; Robert C Noland; Jean-Paul Kovalik; Sarah E Seiler; Michael N Davies; Karen L DeBalsi; Olga R Ilkayeva; Robert D Stevens; Indu Kheterpal; Jingying Zhang; Jeffrey D Covington; Sudip Bajpeyi; Eric Ravussin; William Kraus; Timothy R Koves; Randall L Mynatt Journal: Cell Metab Date: 2012-05-02 Impact factor: 27.287
Authors: Chin Meng Khoo; Michael J Muehlbauer; Robert D Stevens; Zehra Pamuklar; Jiegen Chen; Christopher B Newgard; Alfonso Torquati Journal: Ann Surg Date: 2014-04 Impact factor: 12.969
Authors: Hong Chang Tan; Jean W Hsu; E Shyong Tai; Shaji Chacko; Vieon Wu; Chun Fan Lee; Jean-Paul Kovalik; Farook Jahoor Journal: Front Endocrinol (Lausanne) Date: 2022-06-09 Impact factor: 6.055
Authors: Angela S Koh; Fei Gao; Ru S Tan; Liang Zhong; Shuang Leng; Xiaodan Zhao; Kevin T Fridianto; Jianhong Ching; Si Y Lee; Bryan M H Keng; Tee Joo Yeo; Shu Y Tan; Hong C Tan; Chin T Lim; Woon-Puay Koh; Jean-Paul Kovalik Journal: Clin Cardiol Date: 2018-10 Impact factor: 2.882
Authors: Brian D Piccolo; James L Graham; Kimber L Stanhope; Oliver Fiehn; Peter J Havel; Sean H Adams Journal: Am J Physiol Endocrinol Metab Date: 2016-04-19 Impact factor: 4.310
Authors: Malou A H Nuijten; Thijs M H Eijsvogels; Valerie M Monpellier; Ignace M C Janssen; Eric J Hazebroek; Maria T E Hopman Journal: Obes Rev Date: 2021-10-19 Impact factor: 10.867
Authors: Sarah J Borengasser; Peter R Baker; Mattie E Kerns; Leland V Miller; Alexandra P Palacios; Jennifer F Kemp; Jamie E Westcott; Seth D Morrison; Teri L Hernandez; Ana Garces; Lester Figueroa; Jacob E Friedman; K Michael Hambidge; Nancy F Krebs Journal: Nutrients Date: 2018-09-11 Impact factor: 5.717